Affiliations
AffiliationItem in Clipboard
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco controlAhmedin Jemal et al. J Natl Cancer Inst. 2008.
. 2008 Dec 3;100(23):1672-94. doi: 10.1093/jnci/djn389. Epub 2008 Nov 25. Authors Ahmedin Jemal 1 , Michael J Thun, Lynn A G Ries, Holly L Howe, Hannah K Weir, Melissa M Center, Elizabeth Ward, Xiao-Cheng Wu, Christie Eheman, Robert Anderson, Umed A Ajani, Betsy Kohler, Brenda K Edwards AffiliationItem in Clipboard
AbstractBackground: The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updated information on cancer occurrence and trends in the United States. This year's report includes trends in lung cancer incidence and death rates, tobacco use, and tobacco control by state of residence.
Methods: Information on invasive cancers was obtained from the NCI, CDC, and NAACCR and information on mortality from the CDC's National Center for Health Statistics. Annual percentage changes in the age-standardized incidence and death rates (2000 US population standard) for all cancers combined and for the top 15 cancers were estimated by joinpoint analysis of long-term (1975-2005) trends and by least squares linear regression of short-term (1996-2005) trends. All statistical tests were two-sided.
Results: Both incidence and death rates from all cancers combined decreased statistically significantly (P < .05) in men and women overall and in most racial and ethnic populations. These decreases were driven largely by declines in both incidence and death rates for the three most common cancers in men (lung, colorectum, and prostate) and for two of the three leading cancers in women (breast and colorectum), combined with a leveling off of lung cancer death rates in women. Although the national trend in female lung cancer death rates has stabilized since 2003, after increasing for several decades, there is prominent state and regional variation. Lung cancer incidence and/or death rates among women increased in 18 states, 16 of them in the South or Midwest, where, on average, the prevalence of smoking was higher and the annual percentage decrease in current smoking among adult women was lower than in the West and Northeast. California was the only state with decreasing lung cancer incidence and death rates in women.
Conclusions: Although the decrease in overall cancer incidence and death rates is encouraging, large state and regional differences in lung cancer trends among women underscore the need to maintain and strengthen many state tobacco control programs.
FiguresFigure 1
Trends in age-standardized lung cancer…
Figure 1
Trends in age-standardized lung cancer incidence and death rates by sex, United States,…
Figure 1Trends in age-standardized lung cancer incidence and death rates by sex, United States, 1975–2005. Solid lines represent fitted values based on joinpoint analyses. Squares represent observed rates. SEER-9 incidence data for 1975–2005 are from the Surveillance, Epidemiology, and Ends Results (SEER)-9 areas and or cover 10% of the US population. US incidence data from 1996 to 2005 are from 29 SEER and or National Program of Cancer Registries areas reported by the North American Association of Central Cancer Registries as meeting high-quality data standards and cover about 65% of the US population. SEER-9 incidence data are adjusted for delays in reporting, but US incidence data are not. US and SEER-9 mortality data for 1975–2005 are from the National Center for Health Statistics, 2005 Mortality Special Research File.
Figure 2
Trends in age-specific lung cancer…
Figure 2
Trends in age-specific lung cancer incidence rates by year of diagnosis and sex,…
Figure 2Trends in age-specific lung cancer incidence rates by year of diagnosis and sex, United States, 1975–2005. Data are from Surveillance, Epidemiology, and Ends Results (SEER)-9 areas, and data points are based on 2-y average rates with the exception of the last point, which averages 3-y rates (1975–1976, 1977–1978, …, 2001–2002, 2003–2005). The SEER-9 areas cover about 10% of the US population.
Figure 3
Trends in age-specific lung cancer…
Figure 3
Trends in age-specific lung cancer death rates by year of death and sex,…
Figure 3Trends in age-specific lung cancer death rates by year of death and sex, United States, 1950–2005. Rates include cancers of the lung, bronchus, pleura, and trachea. Data are from the National Center for Health Statistics, 2005 Mortality Special Research File.
Figure 4
Trends in age-specific lung cancer…
Figure 4
Trends in age-specific lung cancer death rates by year of birth and sex,…
Figure 4Trends in age-specific lung cancer death rates by year of birth and sex, United States, 1865–1970. Rates include cancers of the lung, bronchus, pleura, and trachea. The points vertically above each cohort year portray the cohort's age-specific mortality experience. Data are from the National Center for Health Statistics, 2005 Mortality Special Research File.
Figure 5
Trends in age-standardized lung cancer…
Figure 5
Trends in age-standardized lung cancer death rate for the US and selected states…
Figure 5Trends in age-standardized lung cancer death rate for the US and selected states by sex, 1975–2005. Solid lines represent fitted values based on joinpoint analyses. Squares represent observed rates. Data are from the National Center for Health Statistics, 2005 Mortality Special Research File.
Figure 6
Initiation of smoking among 12-…
Figure 6
Initiation of smoking among 12- to 17-year-old adolescents in the United States by…
Figure 6Initiation of smoking among 12- to 17-year-old adolescents in the United States by sex, 1940–2000. All calculations to determine the year in which respondents began smoking were based on the survey administration date in conjunction with responses given in the survey regarding initiation age of “regular” use and current age. Data are from the Tobacco Use Supplements to the Current Population Survey (25,26). Means and 95% confidence intervals (error bars) are shown.
Similar articlesEdwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA. Edwards BK, et al. Cancer. 2010 Feb 1;116(3):544-73. doi: 10.1002/cncr.24760. Cancer. 2010. PMID: 19998273 Free PMC article.
Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Weir HK, et al. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Edwards BK, et al. J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289. J Natl Cancer Inst. 2005. PMID: 16204691
Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, Sherman RL, Wu M, Benard VB, Richardson LC, Jemal A, Cronin K, Kohler BA. Henley SJ, et al. Cancer. 2020 May 15;126(10):2225-2249. doi: 10.1002/cncr.32802. Epub 2020 Mar 12. Cancer. 2020. PMID: 32162336 Free PMC article.
Cresanta JL. Cresanta JL. Prim Care. 1992 Sep;19(3):419-41. Prim Care. 1992. PMID: 1410056 Review.
Min HY, Lee HY. Min HY, et al. Exp Mol Med. 2022 Oct;54(10):1670-1694. doi: 10.1038/s12276-022-00864-3. Epub 2022 Oct 12. Exp Mol Med. 2022. PMID: 36224343 Free PMC article. Review.
Handke NA, Rupp ABA, Trimpop N, von Pawel J, Holdenrieder S. Handke NA, et al. Diagnostics (Basel). 2021 Feb 20;11(2):356. doi: 10.3390/diagnostics11020356. Diagnostics (Basel). 2021. PMID: 33672622 Free PMC article.
Song W, Jeon HG. Song W, et al. Korean J Urol. 2015 Jun;56(6):422-8. doi: 10.4111/kju.2015.56.6.422. Epub 2015 May 27. Korean J Urol. 2015. PMID: 26078838 Free PMC article. Review.
Imperiale TF, Glowinski EA, Lin-Cooper C, Ransohoff DF. Imperiale TF, et al. Am J Med. 2012 Dec;125(12):1181-7. doi: 10.1016/j.amjmed.2012.05.026. Epub 2012 Oct 9. Am J Med. 2012. PMID: 23062404 Free PMC article.
Clark C, Shah S, Herman-Ferdinandez L, Ekshyyan O, Abreo F, Rong X, McLarty J, Lurie A, Milligan EJ, Nathan CO. Clark C, et al. Laryngoscope. 2010 Jun;120(6):1159-65. doi: 10.1002/lary.20917. Laryngoscope. 2010. PMID: 20513033 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3